Gross-to-Net Improving Gross-to-Net Estimates through Better Channel Analytics Part 2 August 29, 2023 Brittany HoneycuttDirector, Gross to Net - Managed Services Aaron LightSolutions Manager Haley MorgayloLead Consultant, Inventory Analytics Tom TravagliniSenior Manager, Industry Solutions 2 Minute Read This is the second and last installment of our two-part blog post covering our webinar series discussing the advantages that channel analytics and downstream inventory analytics have when it comes to gross-to-net calculations. The Importance of Channel Analytics to Gross-to-Net Manufacturers of brand products typically utilize a demand-and-pipeline accrual methodology to support monthly and/or quarterly accrual processes. This allows them to calculate more precise accruals and maintain visibility of the balance sheet at each NDC and contract level. This methodology, however, requires reliable demand and inventory data. Utilizing channel analytics provides insights into demand and total pipeline inventory. Total pipeline inventory consists of distributor inventory and downstream inventory. In Gross-to-Net (GTN), manufacturers take the monthly total pipeline inventory values, demand values, and apply GTN assumptions such as contract rate, utilization mix, and WAC price. End-to-End Roll Forward Enable Gross-to-Net Stakeholders End-to-end Inventory Roll Forward support is a service IntegriChain provides for our ICyte Platform customers who leverage our GTN, Channel Data Aggregation, and Inventory Analytics solutions. This provides our customers with the tools they need to align pipeline and demand figures that improve the gross-to-net close process. End-to-end inventory roll forward provides data that confirms the inputs of inventory pipeline demand sales, providing full GTN visibility. GTN users can take the Roll Forward report to build confidence in accuracy and eliminate gaps within the Distributor Channel. A robust end-to-end roll forward enables manufacturers to reconcile to revenue recognized in the period while also accruing to appropriate estimates for pipeline (distributor inventory, downstream inventory) and demand. This deep dive roll forward builds confidence in channel data as we are easily able to isolate and explain data discrepancies. In the first session we looked at common distributor variances in reporting of inventory. Some of those variances are: Wholesaler Inventory Roll Forward Cross data validations Monthly Sales reconciliation to Wholesaler Receipts Estimating demand and downstream inventory has been a challenge across the industry for decades. Common methodologies that leveraged today compromise the ability to accurately estimate demand and inventory levels downstream. In a use case shared during the last webinar, we applied IntegriChain’s methodology and expertise to triangulate data points and as a result, this customer was able to decrease their reserves drastically. We often see the pain points pharmaceutical Finance teams have, in terms of identifying how much inventory is in the pipeline and how this explains the need for a data-based approach for estimating downstream inventory. Common ways manufacturers estimate downstream inventory are: Applying wholesaler to downstream Pharmacy survey methodology that doesn’t cover any atypical distribution 3rd Party roll forwards There are multiple use cases IntegriChain’s Inventory Analytics provide in addition to accrual management. It helps manufacturers in forecasting, syndicated data adjustment, and with the ability to understand market events. IntegriChain does not use projected demand data but rather a data-based approach in estimating downstream inventory. Our downstream inventory roll forward estimation process highlights the use of our National Data for the Net Sell-In component paired with Pharmacy Claims Data from our partnership with PurpleLab. Our industry based assumptions are also gathered from our Analog Benchmarking and market insights In conclusion of this webinar series, the we presented a full end-to-end Inventory Roll Forward model that incorporates best practices discussed in both Wholesaler reporting as well as Downstream estimations. These are critical components as we look to optimize our GTN models regarding total pipeline, gross sales recognition, and demand. In case you missed this series and have questions regarding these topics, please catch us at our Access Insights Conference in November. About the Author Brittany Honeycutt Director, Gross to Net - Managed Services Brittany Honeycutt leads IntegriChain’s GTN BPaaS and SaaS practice. She and her team partner with dozens of Pharma innovators to deliver GTN automation through the ICyte Platform, including data-driven GTN Accruals, Forecasting, and Analytics and provide timely financial reporting and better business insights to Finance teams. Additionally, Brittany supports our customers and our platforms by adding her specialized knowledge over the impact channel data has in GTN. Brittany is a SME over End to End inventory reconciliations managing data from ex-factory sales, to pipeline levels, to demand utilization. Brittany has over 10 years of GTN industry experience and started her career as an external auditor. You will find Brittany sharing her passions over GTN and Inventory management on webinars and at conferences. Brittany is a CPA and holds a master’s in accounting from UNC Chapel Hill. About the Author Aaron Light Solutions Manager As a Solutions Manager for IntegriChain, Aaron guides Life Sciences manufacturers as they evaluate gross-to-net automation and Contracts & Pricing solutions through a pre-sales process. Through his work at IntegriChain, he has advised and led projects for numerous top-20, mid-market, and emerging manufacturers on GTN automation systems, government pricing, and systems integration, marrying the needs of Market Access teams with technology capabilities. About the Author Haley Morgaylo Lead Consultant, Inventory Analytics About the Author Tom Travaglini Senior Manager, Industry Solutions Tom Travaglini is a Senior Manager on IntegriChain’s Industry Solutions team, specifically focused on the Gross-to-Net and Contract & Pricing segments. Experienced and dedicated professional, with a demonstrated history of working in the information technology and pharmaceutical industries. Previously, Tom had roles in Software Implementation, Advisory Services, and contracting with a top-5 big Pharma organization.
Market Access Blogs December 19, 2024 The Future of 340B and Independent Pharmacies in a Post-IRA World 5 Minute Read
Corporate December 10, 2024 Expansion of Data Quality Monitoring and Inventory Roll Forward 2 Minute Read